Antibodies to thymic hormone and HLA-DQ in type I diabetes

Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease.

The journal of prevention of Alzheimer's disease·2024

JCV seroconversion rate during the SARS COVID-19 pandemic.

Multiple sclerosis and related disorders·2022

Reinforcing the evidence of oligoclonal bands as a prognostic factor in patients with Multiple sclerosis.

Multiple sclerosis and related disorders·2021

Simultaneous measurement of all thermoelectric properties of bulk materials in the temperature range 300-600 K.

The Review of scientific instruments·2015

Histocompatibility antigens and chemical reactivity in autoimmunity.

Immunology today·2014

Humoral or cellular effector mechanisms?

Immunology today·2014

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Howell-Jolly Body-Like Inclusions in a Case of Puerperal Sepsis: A Morphological Enigma.

Journal of microscopy and ultrastructure·2026

Case report of anti-vimentin IgG-associated autoimmune encephalitis: diagnostic challenges and the role of 18F-DPA714 PET/MRI.

BMJ neurology open·2026

Related Experiment Videos

Antibodies to thymic hormone and HLA-DQ in type I diabetes

Related Concept Videos

Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease.

JCV seroconversion rate during the SARS COVID-19 pandemic.

Reinforcing the evidence of oligoclonal bands as a prognostic factor in patients with Multiple sclerosis.

Simultaneous measurement of all thermoelectric properties of bulk materials in the temperature range 300-600 K.

Histocompatibility antigens and chemical reactivity in autoimmunity.

Humoral or cellular effector mechanisms?

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Howell-Jolly Body-Like Inclusions in a Case of Puerperal Sepsis: A Morphological Enigma.

Case report of anti-vimentin IgG-associated autoimmune encephalitis: diagnostic challenges and the role of 18F-DPA714 PET/MRI.

Related Experiment Videos

Antibodies to thymic hormone and HLA-DQ in type I diabetes

Related Concept Videos

Related Articles